V. Chistyakov

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Gunnar Folprecht, Carles Pericay, Mark Saunders et al. · Annals of Oncology · 2016 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

LBA27 Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results from the NORSE study

Thomas Powles, V. Chistyakov, V. Beliakouski et al. · Annals of Oncology · 2021 · 15 citations

Medicine, Oncology, Pharmacology +14